Agent Orange researcher dies
James Whitlock, MD, a professor emeritus of molecular pharmacology (now chemical and systems biology), who discovered the negative effects of dioxin on the human body, died at home.
Data science meets cardiac science
While cardiac sphericity was the focus of Stanford Medicine-led research, the possibility of data science expanding the reach of biomedical science was its true core, researchers say.
mRNA vaccine beats infection
Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.
Osteoarthritis linked to allergic inflammation
A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.
Myc-caused sugar changes protect cancers
A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.
Match Day celebration
“So excited I had to fight back tears”: Stanford School of Medicine students celebrate the next phase in their journey toward becoming full-fledged physicians.
Bryan Myers dies at 86
The Stanford Medicine professor emeritus of nephrology was chief of the Division of Nephrology for nearly 20 years, training nephrologists who now practice around the world.
State of Stanford Medicine
At the annual state of Stanford Medicine address, leaders unveiled plans to refresh the integrated strategic plan and to continue implementing the Commission on Justice and Equity’s recommendations.
Stanford Medicine gives to the community
Stanford Medicine donated more than $950 million in funds and services during the 2022 fiscal year, focusing on access to health care, housing and nutrition.
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.